Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ninan

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Psychopharmacology Bulletin|October 21, 2003
Obsessive-compulsive disorder: implications of the efficacy of an SSRI, paroxetinePhilip T Ninan
Psychopharmacology Bulletin|October 26, 2002
New insights into the diagnosis and pharmacologic management of generalized anxiety disorderPhilip T Ninan
Psychopharmacology Bulletin|October 26, 2002
Social anxiety disorder and the neurobiology of social relationshipsPhilip T Ninan
The Journal of Clinical Psychiatry|October 2, 2001
Dissolving the burden of generalized anxiety disorderP T Ninan
Journal of the Medical Association of Georgia|November 1, 1988
Schizophrenia and its treatmentP T Ninan
Psychopharmacology Bulletin|October 26, 2002
Generalized anxiety disorder: diagnosis, neurobiology, and treatmentP T Ninan
Depression and Anxiety|December 1, 2000
Use of venlafaxine in other psychiatric disordersP T Ninan
The Journal of Clinical Psychiatry|January 14, 2000
The functional anatomy, neurochemistry, and pharmacology of anxietyP T Ninan
The Journal of Clinical Psychiatry|January 1, 1997
Issues in the assessment of treatment response in panic disorder with special reference to fluvoxamineP T Ninan
Psychopharmacology Bulletin|October 26, 2002
Pharmacokinetically induced benzodiazepine withdrawalP T Ninan
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Psychopharmacology Bulletin|October 21, 2003
Obsessive-compulsive disorder: implications of the efficacy of an SSRI, paroxetinePhilip T Ninan
Psychopharmacology Bulletin|October 26, 2002
New insights into the diagnosis and pharmacologic management of generalized anxiety disorderPhilip T Ninan
Psychopharmacology Bulletin|October 26, 2002
Social anxiety disorder and the neurobiology of social relationshipsPhilip T Ninan
The Journal of Clinical Psychiatry|October 2, 2001
Dissolving the burden of generalized anxiety disorderP T Ninan
Journal of the Medical Association of Georgia|November 1, 1988
Schizophrenia and its treatmentP T Ninan
Psychopharmacology Bulletin|October 26, 2002
Generalized anxiety disorder: diagnosis, neurobiology, and treatmentP T Ninan
Depression and Anxiety|December 1, 2000
Use of venlafaxine in other psychiatric disordersP T Ninan
The Journal of Clinical Psychiatry|January 14, 2000
The functional anatomy, neurochemistry, and pharmacology of anxietyP T Ninan
The Journal of Clinical Psychiatry|January 1, 1997
Issues in the assessment of treatment response in panic disorder with special reference to fluvoxamineP T Ninan
Psychopharmacology Bulletin|October 26, 2002
Pharmacokinetically induced benzodiazepine withdrawalP T Ninan
Pageof 12